Metlife Inc (NYSE:MET) EVP Steven J. Goulart sold 14,200 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $51.60, for a total transaction of $732,720.00. Following the completion of the sale, the executive vice president now owns 127,130 shares of the company’s stock, valued at $6,559,908. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of MET stock opened at $52.38 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.14 and a quick ratio of 0.15. The firm has a market cap of $47.71 billion, a PE ratio of 8.66, a price-to-earnings-growth ratio of 1.19 and a beta of 1.07. The company has a 50-day moving average of $51.45 and a two-hundred day moving average of $48.50. Metlife Inc has a 1-year low of $41.41 and a 1-year high of $53.28.
Metlife (NYSE:MET) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.98 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.40 by $0.58. The business had revenue of $18.15 billion for the quarter, compared to analysts’ expectations of $16.82 billion. Metlife had a net margin of 8.39% and a return on equity of 9.14%. The business’s quarterly revenue was up 17.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.35 earnings per share. Sell-side analysts anticipate that Metlife Inc will post 6.1 EPS for the current fiscal year.
MET has been the subject of a number of analyst reports. ValuEngine raised shares of Metlife from a “strong sell” rating to a “sell” rating in a report on Saturday, December 21st. Wells Fargo & Co reissued a “buy” rating on shares of Metlife in a report on Monday, January 6th. Morgan Stanley raised shares of Metlife from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $55.00 to $60.00 in a report on Tuesday, January 7th. Royal Bank of Canada reissued a “buy” rating and issued a $57.00 price objective on shares of Metlife in a report on Sunday, February 9th. Finally, Credit Suisse Group dropped their price objective on shares of Metlife from $63.00 to $60.00 and set an “outperform” rating for the company in a report on Monday, February 3rd. Two research analysts have rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $52.60.
Several institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. lifted its position in shares of Metlife by 1.9% during the second quarter. BlackRock Inc. now owns 72,819,515 shares of the financial services provider’s stock worth $3,616,945,000 after purchasing an additional 1,385,433 shares in the last quarter. FMR LLC lifted its position in shares of Metlife by 1.6% during the fourth quarter. FMR LLC now owns 34,976,649 shares of the financial services provider’s stock worth $1,782,760,000 after purchasing an additional 554,242 shares in the last quarter. Diamond Hill Capital Management Inc. lifted its position in shares of Metlife by 0.6% during the third quarter. Diamond Hill Capital Management Inc. now owns 9,991,921 shares of the financial services provider’s stock worth $471,219,000 after purchasing an additional 57,004 shares in the last quarter. AJO LP lifted its position in shares of Metlife by 26.2% during the fourth quarter. AJO LP now owns 3,682,448 shares of the financial services provider’s stock worth $187,693,000 after purchasing an additional 765,110 shares in the last quarter. Finally, Jennison Associates LLC lifted its position in shares of Metlife by 2.6% during the fourth quarter. Jennison Associates LLC now owns 3,527,868 shares of the financial services provider’s stock worth $179,815,000 after purchasing an additional 88,853 shares in the last quarter. 74.45% of the stock is currently owned by institutional investors and hedge funds.
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Further Reading: Municipal Bonds
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.